Topic
Immunotherapy
62 Podcasts • 36 Cases • 9 Courses on BackTable
Hear how experienced physicians approach Immunotherapy on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering patient selection, workup, and procedure technique. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 75 • 04 Aug 2026
Applying CheckMate 8HW: Practical Updates for MSI-High CRC
with Dr. Cathy Eng, Dr. Jun Gong
Is it time to rethink the definition of “cure” for stage IV colorectal cancer? In this episode of BackTable Tumor Board, medical oncologist Jun Gong interviews Dr. Cathy Eng about updates from the phase III CheckMate-8HW trial in centrally confirmed MSI-high/dMMR metastatic colorectal cancer, comparing nivolumab/ipilimumab, nivolumab, and chemotherapy. They discuss initial findings demonstrating improved progression-free survival and response rates with combination immunotherapy, as well as safety considerations and how comorbidities and frailty guide the choice between single-agent and combination regimens.
This podcast is supported by
More on Immunotherapy
Loading recent podcasts…
Tumor Board # 75
Aug 3, 2026
with Dr. Cathy Eng, Dr. Jun Gong
Is it time to rethink the definition of “cure” for stage IV colorectal cancer? In this episode of BackTable Tumor...
280+ listens
Industry # 103
Jun 29, 2026
with Dr. Basil Kahwash, Anish Parikh
How do you protect your time, stay current, and thrive after leaving academic medicine for private practice in a...
150+ listens
ENT & Allergy # 279
Jun 22, 2026
with Dr. Karen Kaufman, Dr. Ashley Agan
When should recurrent sinus infections trigger an allergy or immune workup? In this episode of the BackTable ENT &...
1,100+ listens
Vascular & IR # 655
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone, Dr. Zach Berman
How is Y90 radioembolization rewriting the rules for managing large HCC tumors and creating new curative-intent...
1,600+ listens
Tumor Board # 74
Jul 27, 2026
with Dr. Chih-Yi Liao, Dr. Robert Ramirez, Dr. Lingling Du
What first-line therapies should be considered for patients with higher-grade, metastatic neuroendocrine tumors (NETs)?...
370+ listens
Vascular & IR # 659
Jun 29, 2026
with Dr. Beau Toskich, Dr. Lingling Du, Dr. Tyler Sandow
How do you safely combine locoregional and systemic therapies to treat hepatocellular carcinoma (HCC) when traditional...
1,300+ listens
Tumor Board # 67
Jun 17, 2026
with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt
Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...
40+ listens
Vascular & IR # 653
Jun 8, 2026
with Dr. Beau Toskich, Dr. Christopher Malone, Dr. Venkatesh Krishnasamy
How can targeted liver radiation unlock surgical or transplant options for tough hepatocellular carcinoma (HCC) cases?...
1,500+ listens
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
Tumor Board Case
Jun 16, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
VI Case
Jun 15, 2026
with Dr. Tyler Sandow, Dr. Beau Toskich, Dr. Christopher Malone and Dr. Zach Berman
Tumor Board Case
Jun 16, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Urology Course
3 hours, 28 lessons
Tumor Board Course
2 CME/CE credits, 2.5 hours, 19 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.